DSM-Firmenich Debuts on Swiss Stock Exchange in Addition to Amsterdam
DSM-Firmenich announced on Thursday the commencement of trading of its ordinary shares on the SIX Swiss Exchange, in addition to its existing presence on Euronext Amsterdam. This dual listing expands access to Swiss institutional investors and enhances the group's visibility in one of Europe's major stock markets.
DSM-Firmenich began trading on the SIX Swiss Exchange on Thursday under the ticker DSFIR. The shares are fully fungible between the two exchanges: Euronext Amsterdam and SIX Swiss Exchange. Trading on the SIX is denominated in Swiss francs, while trading on Euronext Amsterdam remains in euros. The group continues to be held by Euroclear Nederland. Starting from May 22, 2026, DSM-Firmenich will be included in the Swiss Performance Index (SPI) and the SPI Extra, which will enhance the company's profile among Swiss and international investors.
A Strategic Step for the Swiss Group
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
This dual listing strengthens the group's positioning among Swiss and international investors, according to Dimitri de Vreeze, CEO of DSM-Firmenich. It broadens access to capital and solidifies the group's presence in key European stock markets. The group expects this development to support the growth of a diversified and high-quality shareholder base, conducive to long-term value creation. The operation does not involve any issuance of new shares and does not affect the capital structure of DSM-Firmenich.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
